DNTH
Dianthus Therapeutics, Inc.
Stock
$88.21−0.11 (−0.12%)Close Oct 2, 2026
Key figures
| Metric | Last 12 months |
|---|---|
| Revenue | $2.0M |
| Operating income | −$218M |
| Net income | −$192M |
| EPS | −$4.15 |
| Free cash flow | −$156M |
Dianthus Therapeutics, Inc.
$88.21−0.11 (−0.12%)Close Oct 2, 2026
| Metric | Last 12 months |
|---|---|
| Revenue | $2.0M |
| Operating income | −$218M |
| Net income | −$192M |
| EPS | −$4.15 |
| Free cash flow | −$156M |